Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo Velázquez-Moctezuma

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Plos Pathogens|February 24, 2017
Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5ARodrigo Velázquez-Moctezuma, Mansun Law, Jens Bukh, et al.
Journal of Virology|November 30, 2018
Hepatitis C Virus Escape Studies of Human Antibody AR3A Reveal a High Barrier to Resistance and Novel Insights on Viral Antibody Evasion MechanismsRodrigo Velázquez-Moctezuma, Andrea Galli, Mansun Law, et al.
The Journal of Infectious Diseases|August 14, 2018
Hepatitis C Virus-Escape Studies for Human Monoclonal Antibody AR4A Reveal Isolate-Specific Resistance and a High Barrier to ResistanceRodrigo Velázquez-Moctezuma, Andrea Galli, Mansun Law, et al.
Journal of Virological Methods|November 26, 2011
Alternative cell lines to improve the rescue of infectious human astrovirus from a cDNA cloneRodrigo Velázquez-Moctezuma, Ma del Rocío Baños-Lara, Yunuén Acevedo, et al.
Viruses|June 26, 2026
Mapping Determinants of Hepatitis C Virus E1/E2 Transmembrane Interactions Using Intergenotypic ChimerasMargherita Fanalista, Christina Holmboe Olesen, Rodrigo Velázquez-Moctezuma, et al.
Hepatology (Baltimore, Md.)|June 29, 2016
Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivityJannick Prentoe, Rodrigo Velázquez-Moctezuma, Steven K H Foung, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2019
Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformationsJannick Prentoe, Rodrigo Velázquez-Moctezuma, Elias H Augestad, et al.
Vaccines|April 3, 2021
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing AntibodiesRodrigo Velázquez-Moctezuma, Elias H Augestad, Matteo Castelli, et al.
Gut|November 22, 2015
HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised miceJannick Prentoe, Lieven Verhoye, Rodrigo Velázquez Moctezuma, et al.
Cellular and Molecular Gastroenterology and Hepatology|November 19, 2025
In Vivo Determinants of Hepatitis C Virus Adaptation and Escape From Neutralizing Antibody AR5ARodrigo Velázquez-Moctezuma, Rani Burm, Lieven Verhoye, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Plos Pathogens|February 24, 2017
Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5ARodrigo Velázquez-Moctezuma, Mansun Law, Jens Bukh, et al.
Journal of Virology|November 30, 2018
Hepatitis C Virus Escape Studies of Human Antibody AR3A Reveal a High Barrier to Resistance and Novel Insights on Viral Antibody Evasion MechanismsRodrigo Velázquez-Moctezuma, Andrea Galli, Mansun Law, et al.
The Journal of Infectious Diseases|August 14, 2018
Hepatitis C Virus-Escape Studies for Human Monoclonal Antibody AR4A Reveal Isolate-Specific Resistance and a High Barrier to ResistanceRodrigo Velázquez-Moctezuma, Andrea Galli, Mansun Law, et al.
Journal of Virological Methods|November 26, 2011
Alternative cell lines to improve the rescue of infectious human astrovirus from a cDNA cloneRodrigo Velázquez-Moctezuma, Ma del Rocío Baños-Lara, Yunuén Acevedo, et al.
Viruses|June 26, 2026
Mapping Determinants of Hepatitis C Virus E1/E2 Transmembrane Interactions Using Intergenotypic ChimerasMargherita Fanalista, Christina Holmboe Olesen, Rodrigo Velázquez-Moctezuma, et al.
Hepatology (Baltimore, Md.)|June 29, 2016
Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivityJannick Prentoe, Rodrigo Velázquez-Moctezuma, Steven K H Foung, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2019
Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformationsJannick Prentoe, Rodrigo Velázquez-Moctezuma, Elias H Augestad, et al.
Vaccines|April 3, 2021
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing AntibodiesRodrigo Velázquez-Moctezuma, Elias H Augestad, Matteo Castelli, et al.
Gut|November 22, 2015
HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised miceJannick Prentoe, Lieven Verhoye, Rodrigo Velázquez Moctezuma, et al.
Cellular and Molecular Gastroenterology and Hepatology|November 19, 2025
In Vivo Determinants of Hepatitis C Virus Adaptation and Escape From Neutralizing Antibody AR5ARodrigo Velázquez-Moctezuma, Rani Burm, Lieven Verhoye, et al.
Pageof 2